Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 1156 AL 1170

Co-twin design in brain imaging-review on biomarkers of Alzheimer's disease

Varjonen A, Schwarz C, Vuoksimaa E.

Cereb Cortex. 2023 Jul 5;33(14):9054-9066. doi: 10.1093/cercor/bhad181.

Fluorescent Sensing Platforms for Detecting and Imaging the Biomarkers of Alzheimer's Disease

Liu X, Liu Y, Liu Q.

Biosensors (Basel). 2023 Apr 30;13(5):515. doi: 10.3390/bios13050515.

CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease

Papaliagkas V, Kalinderi K, Vareltzis P, Moraitou D, Papamitsou T, Chatzidimitriou M.

Int J Mol Sci. 2023 May 19;24(10):8976. doi: 10.3390/ijms24108976.

Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's Disease

Karima S, Aghamollaii V, Mahmoodi Baram S, Balenci L, Lanctôt KL, Kiss A, Tafakhori A, Mahdavi M, Rajaei S, Shateri S, Yarhoseini A, Mokhtari F, Fotouhi A, Riazi A.

J Alzheimers Dis. 2023;94(1):359-370. doi: 10.3233/JAD-221026.

Blood-based biomarkers for Alzheimer's disease: Current state and future use in a transformed global healthcare landscape

Hampel H, Hu Y, Cummings J, Mattke S, Iwatsubo T, Nakamura A, Vellas B, O'Bryant S, Shaw LM, Cho M, Batrla R, Vergallo A, Blennow K, Dage J, Schindler SE.

Neuron. 2023 Sep 20;111(18):2781-2799. doi: 10.1016/j.neuron.2023.05.017. Epub 2023 Jun 8.

Astrocyte Signature in Alzheimer's Disease Continuum through a Multi-PET Tracer Imaging Perspective

Fontana IC, Scarpa M, Malarte ML, Rocha FM, Ausellé-Bosch S, Bluma M, Bucci M, Chiotis K, Kumar A, Nordberg A.

Cells. 2023 May 24;12(11):1469. doi: 10.3390/cells12111469.

Association between lipocalin-2 and mild cognitive impairment or dementia: A systematic review and meta-analysis of population-based evidence

Li X, Wang X, Guo L, Wu K, Wang L, Rao L, Liu X, Kang C, Jiang B, Li Q, Li H, He F, Lu C.

Ageing Res Rev. 2023 Aug;89:101984. doi: 10.1016/j.arr.2023.101984. Epub 2023 Jun 15.

Plasma Aβ biomarker for early diagnosis and prognosis of Alzheimer's disease - a systematic review

Ebbesen SU, Høgh P, Zibrandtsen I.

Dan Med J. 2023 May 10;70(6):A07220446.

Adding the Topographical Information from Tau-PET to the A/T/(N) Framework: Steps Towards Staging AD in Vivo

Therriault J, Gauthier S, Rosa-Neto P.

J Prev Alzheimers Dis. 2023;10(3):381-386. doi: 10.14283/jpad.2023.52.

Charting the Next Road Map for CSF Biomarkers in Alzheimer's Disease and Related Dementias

Hu WT, Nayyar A, Kaluzova M.

Neurotherapeutics. 2023 Jul;20(4):955-974. doi: 10.1007/s13311-023-01370-8. Epub 2023 Jun 28.

Predicting cognitive decline in older people by structural and molecular imaging

Teipel S, Tang Y, Boccardi M.

Curr Opin Neurol. 2023 Aug 1;36(4):253-263. doi: 10.1097/WCO.0000000000001172. Epub 2023 Jun 19.

MRI in the new era of antiamyloid mAbs for the treatment of Alzheimer's disease

Filippi M, Cecchetti G, Agosta F.

Curr Opin Neurol. 2023 Aug 1;36(4):239-244. doi: 10.1097/WCO.0000000000001177. Epub 2023 Jun 23.

Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers

Gibson LL, Abdelnour C, Chong J, Ballard C, Aarsland D.

Curr Opin Neurol. 2023 Aug 1;36(4):264-275. doi: 10.1097/WCO.0000000000001173. Epub 2023 Jun 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias